- Home
- CRBP vs MFIN Comparison
CRBP vs MFIN Comparison
Compare CRBP & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- MFIN
- Stock Information
- Founded
- CRBP 2009
- MFIN 1995
- Country
- CRBP United States
- MFIN United States
- Employees
- CRBP 19
- MFIN N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- MFIN Finance: Consumer Services
- Sector
- CRBP Health Care
- MFIN Finance
- Exchange
- CRBP Nasdaq
- MFIN Nasdaq
- Market Cap
- CRBP 158.3M
- MFIN 190.0M
- IPO Year
- CRBP N/A
- MFIN 1996
- Fundamental
- Price
- CRBP $13.00
- MFIN $9.70
- Analyst Decision
- CRBP Strong Buy
- MFIN
- Analyst Count
- CRBP 8
- MFIN 0
- Target Price
- CRBP $62.00
- MFIN N/A
- AVG Volume (30 Days)
- CRBP 313.3K
- MFIN 75.5K
- Earning Date
- CRBP 11-07-2024
- MFIN 02-18-2025
- Dividend Yield
- CRBP N/A
- MFIN 4.50%
- EPS Growth
- CRBP N/A
- MFIN N/A
- EPS
- CRBP N/A
- MFIN 1.69
- Revenue
- CRBP N/A
- MFIN $293,257,000.00
- Revenue This Year
- CRBP N/A
- MFIN N/A
- Revenue Next Year
- CRBP N/A
- MFIN $10.95
- P/E Ratio
- CRBP N/A
- MFIN $5.78
- Revenue Growth
- CRBP N/A
- MFIN 18.48
- 52 Week Low
- CRBP $5.25
- MFIN $6.48
- 52 Week High
- CRBP $61.90
- MFIN $10.50
- Technical
- Relative Strength Index (RSI)
- CRBP 25.10
- MFIN 48.17
- Support Level
- CRBP $12.90
- MFIN $9.32
- Resistance Level
- CRBP $16.21
- MFIN $10.50
- Average True Range (ATR)
- CRBP 0.95
- MFIN 0.33
- MACD
- CRBP -0.16
- MFIN -0.03
- Stochastic Oscillator
- CRBP 1.69
- MFIN 25.83
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. Its operating segments include recreation, home improvement, commercial lending, medallion lending and Corporate and Other Investments. The company generates maximum revenue from the Recreation segment.